Tami Orton
Psychiatric/Mental Health · Lincoln, NENPI 1407452873
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,639 of the $7,638 with a category attached, or 86.9%. It is spread thinly across 25 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 337 payments — averaging $22.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$977
- Otsuka America Pharmaceutical, Inc.$468
- Jazz Pharmaceuticals Inc.$408
- Teva Pharmaceuticals USA, Inc.$393
- plus $2K from 19 others
What the payments were for
- Travel & lodging$89912%
- Food & beverage$6,63987%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 31 | $1,694 |
| AbbVie | 110 | $1,535 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 42 | $977 |
| Otsuka America Pharmaceutical, Inc. | 22 | $468 |
| Jazz Pharmaceuticals Inc. | 18 | $408 |
| Teva Pharmaceuticals USA, Inc. | 17 | $393 |
| Axsome Therapeutics, Inc. | 10 | $310 |
| E.r. Squibb & Sons, L.L.C. | 17 | $304 |
| Neurocrine Biosciences, Inc. | 12 | $259 |
| Supernus Pharmaceuticals, Inc. | 10 | $222 |
| Alkermes, Inc. | 7 | $216 |
| Harmony Biosciences LLC | 6 | $173 |
| Vanda Pharmaceuticals Inc. | 3 | $95 |
| Tris Pharma Inc | 4 | $90 |
| Lundbeck LLC | 5 | $88 |
| Noven Therapeutics, LLC | 4 | $76 |
| Idorsia Pharmaceuticals US Inc | 1 | $64 |
| Neos Therapeutics, LP | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Corium, LLC | 4 | $48 |
| Sunovion Pharmaceuticals Inc. | 3 | $36 |
| Biogen | 2 | $30 |
| Indivior Inc. | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,638 in reported general payments places this provider in the 90th percentile of 255 psychiatric/mental health providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 38 | $55,482 |
| Paliperidone ErPaliperidone | 26 | $4,776 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 49 | $2,260 |
| Aripiprazole | 55 | $2,132 |
| Bupropion XlBupropion Hcl | 51 | $762 |
| Quetiapine Fumarate | 58 | $751 |
| Trazodone Hcl | 67 | $621 |
| Hydroxyzine Hcl | 44 | $547 |
| Fluoxetine Hcl | 64 | $545 |
| Risperidone | 50 | $530 |
| Sertraline Hcl | 71 | $491 |
| Olanzapine | 16 | $403 |
| Prazosin Hcl | 22 | $400 |
| Lamotrigine | 44 | $385 |
| Buspirone Hcl | 41 | $369 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,535 | $55,48238 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 255 psychiatric/mental health providers in Nebraska.
Other psychiatric/mental health in Lincoln
- Helen TrotterLincoln$10K
- Marcia CarlsonLincoln$9K
- Trisha JobmanLincoln$9K
- Cory RabeLincoln$9K
- Kelley HanauLincoln$8K
- Michelle LemonLincoln$7K
- Serena MacauleyLincoln$7K
- Sabrina HellbuschLincoln$7K
- Rebecca OlanderLincoln$7K
- Lisa YoungLincoln$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.